Zoetis | ZTS - Des Atouts





Des Atouts Changement Date
AbbVie USD 136.46B 2.5B 2026-03
Align Technology USD 6.31B 80.48M 2026-03
Bayer EUR 107.94B 3.4B 2026-03
Bristol-Myers Squibb USD 86.48B 3.56B 2026-03
Charles River Laboratories USD 7.73B 594.89M 2026-03
Coherus Biosciences USD 258.34M 258.18M 2025-12
Dentsply International USD 5.23B 200M 2026-03
Eli Lilly USD 116.58B 4.1B 2026-03
Henry Schein USD 11.3B 89M 2026-03
Idexx Laboratories USD 3.39B 34.74M 2026-03
Illumina USD 6.56B 85M 2026-03
IQVIA Holdings USD 29.68B 269M 2026-03
J&J USD 200.89B 1.68B 2026-03
Laboratory Of America USD 19.09B 694.4M 2026-03
Merck USD 128.68B 8.18B 2026-03
Neogen USD 3.36B 953K 2025-12
Pacira USD 1.21B 56.38M 2026-03
Perrigo USD 7.98B 551.9M 2026-03
Pfizer USD 207.62B 542M 2026-03
Phibro Animal Health USD 1.45B 39.56M 2026-03
Quest Diagnostics USD 16.67B 448M 2026-03
Sanofi EUR 128.02B 1.22B 2026-03
Sanofi EUR 128.02B 1.22B 2026-03
Zoetis USD 15.15B 313M 2026-03